Literature DB >> 28858429

Energy imbalance and cancer: Cause or consequence?

Xiaohui Wang1, Wei Liu2, Xiangyang Xie3.   

Abstract

Obesity has been an epidemic worldwide over the past decades and significantly increases the risk of developing a variety of deadly diseases including type 2 diabetes, cardiovascular diseases and many cancers. The relationship between obesity and type 2 diabetes and cardiovascular disease has been well documented. The drastically increased frequency of a number of cancers in obesity has attracted growing interest. On one hand, how increased adiposity promotes cancer development remains poorly understood, despite the fact that considerable epidemiological evidence has suggested links between them. On the other hand, however, numerous studies have shown that tumorigenesis leads to substantial weight loss in a large portion of cancer patients. Here, we summarize the recent advances on our understanding of the link between obesity and cancer development with a focus on the molecular mechanisms accounting for the rising cancer incidence in the context of obesity. In addition, we also discuss how cancer-associated anorexia and cachexia causes weight loss.
© 2017 IUBMB Life, 69(10):776-784, 2017. © 2017 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  adipokine; adiposity; anorexia; cachexia; cancer; inflammation; obesity

Mesh:

Substances:

Year:  2017        PMID: 28858429     DOI: 10.1002/iub.1674

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  2 in total

1.  Changes in midlife fitness, body mass index, and smoking influence cancer incidence and mortality: A prospective cohort study in men.

Authors:  Trude E Robsahm; Trond Heir; Leiv Sandvik; Erik Prestgaard; Steinar Tretli; Jan E Erikssen; Ragnhild S Falk
Journal:  Cancer Med       Date:  2019-07-04       Impact factor: 4.452

2.  Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences.

Authors:  Alexandru Florescu; Dumitru Branisteanu; Stefana Bilha; Dragos Scripcariu; Ioana Florescu; Viorel Scripcariu; Gabriel Dimofte; Ioana Grigoras
Journal:  PLoS One       Date:  2019-08-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.